Join Now

Category Archives: BioUtah News

Investors Buy up Stocks in Biggest Follow-on Offering Day in Biotech History

By Natalie Themm | Published December 11, 2025

Investors Buy up Stocks in Biggest Follow-on Offering Day in Biotech History

| Comments Off on Investors Buy up Stocks in Biggest Follow-on Offering Day in Biotech History

Talent Ready Utah Calling for Innovator Input

By Natalie Themm | Published December 11, 2025

Talent Ready Utah Calling for Innovator Input

| Tagged | Comments Off on Talent Ready Utah Calling for Innovator Input

Owlet Launches TGA-Approved Dream Sock™ in Australia & New Zealand, Expanding International Footprint and Bringing Trusted Pediatric Health Monitoring to More Families Worldwide

By Natalie Themm | Published December 11, 2025

TGA approval enables regional launch of Owlet’s clinically validated, award-winning infant health monitor; Owlet360™ subscription marks first international expansion of the Company’s recurring-revenue platform.

| Tagged | Comments Off on Owlet Launches TGA-Approved Dream Sock™ in Australia & New Zealand, Expanding International Footprint and Bringing Trusted Pediatric Health Monitoring to More Families Worldwide

Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks

By Natalie Themm | Published December 11, 2025

REC-4881 (4 mg QD) achieved rapid clinical activity, with 75% of evaluable patients showing reductions in total polyp burden and a 43% median reduction after 12 weeks of treatment (n=12).

| Tagged | Comments Off on Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks

Halia Therapeutics Announces Positive Phase 2a Data for Ofirnoflast in Lower-Risk MDS at ASH 2025

By Natalie Themm | Published December 11, 2025

New findings demonstrate a 72% HI-E response rate at Week 16 with meaningful hemoglobin improvement.

| Tagged | Comments Off on Halia Therapeutics Announces Positive Phase 2a Data for Ofirnoflast in Lower-Risk MDS at ASH 2025

CLENE ANNOUNCES STATISTICALLY SIGNIFICANT ALS BIOMARKER RESULTS SUPPORTING ACCELERATED APPROVAL PATHWAY FOR CNM-AU8®

By Natalie Themm | Published December 11, 2025

FDA recommended biomarker analyses show statistically significant reductions in NfL and GFAP in participants treated with CNM-Au8.

| Tagged | Comments Off on CLENE ANNOUNCES STATISTICALLY SIGNIFICANT ALS BIOMARKER RESULTS SUPPORTING ACCELERATED APPROVAL PATHWAY FOR CNM-AU8®

Canary Speech Earns Microsoft Solutions Partner: Healthcare AI Certified Software Designation

By Natalie Themm | Published December 11, 2025

Prestigious recognition validates Canary Speech’s leadership in healthcare-focused AI voice technology and its proven interoperability with the Microsoft Cloud

| Tagged | Comments Off on Canary Speech Earns Microsoft Solutions Partner: Healthcare AI Certified Software Designation

bioMérieux Celebrates New Regional Headquarters in Riyadh, Saudi Arabia

By Natalie Themm | Published December 4, 2025

bioMérieux Celebrates New Regional Headquarters in Riyadh, Saudi Arabia

| Tagged | Comments Off on bioMérieux Celebrates New Regional Headquarters in Riyadh, Saudi Arabia

PolarityBio Completes Phase III Pivotal Study of SkinTE for Diabetic Foot Ulcers

By Natalie Themm | Published December 4, 2025

PolarityBio thanks the clinical trial sites and, most importantly, the participants, for making this milestone in DFU biologic therapy development possible

| Tagged | Comments Off on PolarityBio Completes Phase III Pivotal Study of SkinTE for Diabetic Foot Ulcers

SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants

By Natalie Themm | Published December 4, 2025

Milestone enables immediate production of SiN/PEEK custom devices

| Tagged | Comments Off on SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants

5 Trends to Expect From Vocal Biomarker Technology in 2026

By Natalie Themm | Published December 4, 2025

By Henry O’Connell, CEO and co-founder of Canary Speech   Vocal biomarker data has come a long way in a short amount of time. No longer relegated to the pages of science fiction, the power of the human voice to assist in diagnoses is established fact. Providers already possess technological platforms that make informed care […]

| Tagged | Comments Off on 5 Trends to Expect From Vocal Biomarker Technology in 2026

Seek Labs Publishes First Peer-Reviewed Paper Demonstrating A CRISPR-Based Therapeutic Is Effective Against African Swine Fever

By admin | Published November 20, 2025

SALT LAKE CITY, UT (Business Wire) – Seek Labs, a biotechnology company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced the publication of a peer-reviewed paper in Viruses (MDPI), revealing the first successful use of a CRISPR-based therapeutic to treat African Swine Fever Virus (ASFV) in pigs. The […]

| Comments Off on Seek Labs Publishes First Peer-Reviewed Paper Demonstrating A CRISPR-Based Therapeutic Is Effective Against African Swine Fever

A Special Thanks To Our Legacy and Platinum Elite Members